Published 4 days ago • loading... • Updated 4 days ago

Gilead Mobilizes Rapid Donation of Remdesivir to Support Ebola Response

FOSTER CITY, Calif. — Gilead Sciences has made a donation of more than 2,000 vials of its intravenous antiviral therapy, remdesivir, to the Republic of Uganda to support response efforts to the current outbreak of Ebola Bundibugyo virus disease (BVD). This donation, along with the additional supply being readied, continues the company’s long-standing work to address emerging infectious diseases.“At Gilead, we recognize the urgency and human toll…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

redaccionmedica.com

Gilead Mobilizes Remdesivir Donation Against Ebola Outbreak

Gilead Sciences has announced the donation of more than 2000 vials of its intravenous antiviral treatment remdesivir to Uganda, in order to support efforts to respond to the current Ebola outbreak, specifically the Bundibugyo variant, which is particularly concerned by the health authorities about the lack of vaccine availability for this strain. It should be recalled that this outbreak, declared on 15 May, mainly affects the Democratic Republic…

4 days ago

Read Full Article

Medical Device News Magazine

Reposted by

HealthTech HotSpot

Gilead Mobilizes Rapid Donation of Remdesivir to Support Ebola Response, Building on Decade-Long Commitment to Outbreak Relief

nu Osinusi, MD, Vice President, Clinical Development, Virology at Gilead Sciences. “Building on decades of experience responding to serious infectious diseases, our teams are working alongside partners with focus and purpose to support the response to this outbreak.” The post Gilead Mobilizes Rapid Donation of Remdesivir to Support Ebola Response, Building on Decade-Long Commitment to Outbreak Relief first appeared on Medical Device News Magazin…

4 days ago

Read Full Article